Fueling Innovation in Biopharma R&D
Our focus and approach to pharma R&D
Despite tremendous advances in scRNA, Omics, and gene data, areas of target biology and chemical spaces still need to be fully understood. Aganitha is a new generation in silico company that integrates high-throughput sciences with deep learning-based generative models to solve complex drug discovery and development challenges. Our approach focuses on deep sciences and deep tech collaboration and includes:
Wet lab augmentation with in silico techniques
Blending in silico techniques with wet lab approaches, using physics-based chemistry and first principles-based systems biology
Mechanism of Action (MoA)
Examples of solutions we have developed for our clients
We are committed to developing cutting edge in silico solutions to address complex drug discovery and development challenges. Through our extensive research and development efforts, we have developed methodologies and frameworks for tackling some of the most pressing issues in this field.